Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI. - Kraft CS; Sims M; Silverman M; Louie TJ; Feuerstadt P; Huang ES; Khanna S; Berenson CS; Wang EEL; Cohen SH; Korman L; Lee C; et al. (Infectious diseases and therapy, 2024)